Neovasc Inc (NASDAQ:NVCN) (TSE:NVC) traded up 6% on Monday . The company traded as high as $0.54 and last traded at $0.53. 1,500,927 shares were traded during trading, a decline of 23% from the average session volume of 1,941,349 shares. The stock had previously closed at $0.50.
A number of equities research analysts have weighed in on the stock. ValuEngine upgraded shares of Neovasc from a “hold” rating to a “buy” rating in a research note on Friday, March 1st. Zacks Investment Research lowered shares of Neovasc from a “hold” rating to a “sell” rating in a research note on Wednesday, March 27th.
The company has a market cap of $32.81 million, a price-to-earnings ratio of -0.19 and a beta of 1.67.
Neovasc (NASDAQ:NVCN) (TSE:NVC) last announced its earnings results on Thursday, March 21st. The medical equipment provider reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.02). The business had revenue of $0.52 million for the quarter, compared to analyst estimates of $0.60 million. On average, analysts predict that Neovasc Inc will post -0.25 earnings per share for the current fiscal year.
Large investors have recently bought and sold shares of the company. Virtu Financial LLC purchased a new stake in shares of Neovasc in the 4th quarter worth $38,000. Wedbush Securities Inc. purchased a new stake in shares of Neovasc in the 1st quarter worth $53,000. Finally, Perkins Capital Management Inc. purchased a new stake in shares of Neovasc in the 1st quarter worth $234,000. Hedge funds and other institutional investors own 5.63% of the company’s stock.
WARNING: “Neovasc (NVCN) Trading 6% Higher” was originally published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are viewing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this story can be accessed at https://www.thelincolnianonline.com/2019/05/06/neovasc-nvcn-trading-6-higher.html.
Neovasc Company Profile (NASDAQ:NVCN)
Neovasc Inc, a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products.
Featured Article: Dollar Cost Averaging
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.